Plant-Derived Exosome-Like Nanovesicles: Current Progress and Prospects
Nai Mu,Jie Li,Li Zeng,Juan You,Rong Li,Anquan Qin,Xueping Liu,Fang Yan,Zheng Zhou
DOI: https://doi.org/10.2147/IJN.S420748
IF: 7.033
2023-09-06
International Journal of Nanomedicine
Abstract:Nai Mu, 1, 2, &ast Jie Li, 3, &ast Li Zeng, 4 Juan You, 4 Rong Li, 4 Anquan Qin, 4 Xueping Liu, 1 Fang Yan, 3, 5 Zheng Zhou 1, 2 1 Department of Clinical Medicine, North Sichuan Medical College, Nanchong, Sichuan Province, People's Republic of China; 2 Geriatric Diseases Institute of Chengdu, Department of Orthopedics, Chengdu Fifth People's Hospital, Chengdu, Sichuan Province, People's Republic of China; 3 Center for Medicine Research and Translation, Chengdu Fifth People's Hospital, Chengdu, Sichuan Province, People's Republic of China; 4 Department of Pharmacy, Chengdu Fifth People's Hospital, Chengdu, Sichuan Province, People's Republic of China; 5 Geriatric Diseases Institute of Chengdu, Department of Geriatrics, Chengdu Fifth People's Hospital, Chengdu, Sichuan Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Fang Yan; Zheng Zhou, Tel +86 134 0849 8904 ; +86 182 0810 1005, Email ; Exosomes are small extracellular vesicles, ranging in size from 30– 150nm, which can be derived from various types of cells. In recent years, mammalian-derived exosomes have been extensively studied and found to play a crucial role in regulating intercellular communication, thereby influencing the development and progression of numerous diseases. Traditional Chinese medicine has employed plant-based remedies for thousands of years, and an increasing body of evidence suggests that plant-derived exosome-like nanovesicles (PELNs) share similarities with mammalian-derived exosomes in terms of their structure and function. In this review, we provide an overview of recent advances in the study of PELNs and their potential implications for human health. Specifically, we summarize the roles of PELNs in respiratory, digestive, circulatory, and other diseases. Furthermore, we have extensively investigated the potential shortcomings and challenges in current research regarding the mechanism of action, safety, administration routes, isolation and extraction methods, characterization and identification techniques, as well as drug-loading capabilities. Based on these considerations, we propose recommendations for future research directions. Overall, our review highlights the potential of PELNs as a promising area of research, with broad implications for the treatment of human diseases. We anticipate continued interest in this area and hope that our summary of recent findings will stimulate further exploration into the implications of PELNs for human health. Keywords: exosomes, nanocarriers, nanotherapeutics, plants, vesicles Exosomes have been a subject of research since 1983, when Johnstone and Pan et al discovered their release from ovine reticulocytes during in vitro culture. 1 These tiny extracellular vesicles, ranging in size between 30–150nm, 2 are formed by extracellular vesicles via processes such as endocytosis - fusion - exocytosis, and contain proteins, lipids, DNA, and non-coding RNA, among other substances. Subsequent studies have revealed that exosomes can be obtained from cells, tissues, or body fluids of almost all mammalian species. These sources include stem cells, 3–5 cancer cells, 6 immune cells, 7 lung tissue, tumor tissue, 8 blood, urine, 9,10 and others. They have demonstrated excellent molecular transport properties and biocompatibility, making them promising for intercellular and interspecies communication. 11–15 For example, exosomes can directly activate receptors on target cells' surfaces, alter characteristics of targeted cells, be used as carriers to transport proteins, miRNAs, DNA, and various drugs that increase therapeutic efficacy or detection of certain diseases, like the large number of exosomes secreted by tumor cells, which can be used as a more specific indicator of early tumor screening and recurrence monitoring. However, exosomes have limitations, including containing both immune activators and immunosuppressive factors that may reduce host resistance to pathogens, and high extraction difficulty and low purity, which significantly increase exosome production cost. Overcoming these limitations by improving the extraction process and expanding available sources is necessary, and this has led to the discovery of plant-derived exosome-like nanovesicles (PELNs). According to current research, there are three possible pathways for the biogenesis of plant extracellular vesicles: the exocyst-positive organelle (EXPO) pathway, the multivesicular bodies (MVBs) pathway, and the vacuolar pathway. 16,17 Among these, the MVBs pathway is considered the ma -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology